ImmuCell Corporation Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImmuCell Corporation stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $164.97K, a 5499000.00% increase year-over-year.
- ImmuCell Corporation stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $4.00.
- ImmuCell Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00.
- ImmuCell Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00.
- ImmuCell Corporation stock issued during period, value, stock options exercised for fiscal 2025 was $3.00.
- ImmuCell Corporation stock issued during period, value, stock options exercised for fiscal 2023 was $18.76K, a 38.83% decline from fiscal 2022.
- ImmuCell Corporation stock issued during period, value, stock options exercised for fiscal 2022 was $30.67K, a 162.29% increase from fiscal 2021.
- ImmuCell Corporation stock issued during period, value, stock options exercised for fiscal 2021 was $11.69K, a 129822.22% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $164.97K 10-Q · filed 2026-08-13 | $164.98K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.00 10-Q · filed 2026-05-14 | $7.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2025-06-30 | $3.00 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $18.76K 10-K · filed 2025-03-28 | |
| 2022-12-31 | -$2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $30.67K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $30.67K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $24.83K 10-Q · filed 2023-08-10 | $30.67K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $5.84K 10-Q · filed 2023-05-11 | $5.85K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $11.69K 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | |
| 2021-06-30 | $13.00 10-Q/A · filed 2022-11-21 | |
| 2021-03-31 | $11.68K 10-Q/A · filed 2022-11-21 | |
| 2020-12-31 | $9.00 10-K · filed 2022-03-30 | |
| 2019-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $3.00 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $80.76K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $85.40K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $2.00 10-Q · filed 2020-05-13 | $92.10K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $80.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $96.25K 10-K · filed 2020-03-27 |
| 2018-09-30 | $4.64K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $6.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | |
| 2018-03-31 | $4.16K 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $49.56K 10-K · filed 2019-03-22 | |
| 2016-12-31 | $31.98K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $120.21K 10-K · filed 2017-03-30 |
| 2015-09-30 | $75.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $120.21K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-06-30 | $39.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $45.14K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-03-31 | $5.25K 10-Q · filed 2016-05-11 | $5.25K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $3.15K 10-K · filed 2016-03-25 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | |
| 2014-03-31 | $3.15K 10-Q · filed 2015-05-12 | |
| 2013-12-31 | $21.75K 10-K · filed 2016-03-25 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $50.80K 10-K · filed 2015-03-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $67.92K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $165.72K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $50.80K 10-Q · filed 2013-05-14 | |
| 2011-12-31 | $17.13K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $145.29K 10-K · filed 2014-03-26 |
| 2011-09-30 | $97.80K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | |
| 2010-12-31 | $6.00K 10-K · filed 2013-03-28 | |
| 2009-12-31 | $99.75K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |